Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit SAN DIEGO, Calif. — Executive Chairman and former CEO of Maravai LifeSciences, Inc. (NASDAQ: MRVI) Carl Hull, has been reinstated as CEO of the company on an interim basis. Three subsidiaries of Danaher Corporation, two of which previously employed recently-appointed Maravai CEO William “Trey” […]
– New function provides better information for data analysis and cancer diagnostics Nasdaq First North-listed Qlucore, whose software creates the conditions for faster, more precise, better cancer diagnostics and helps researchers with data analysis, has received a patent in Europe. This is for a new feature which generates robust analysis answers, even in the presence […]
Bio-Techne enforces intellectual property for gold standard RNAscope® ISH technology in spatial biology and clinical applications. MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that it has taken legal action in the United Kingdom to halt the infringement of its patented […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), today received a decision from the European Commission prohibiting the company’s acquisition of GRAIL. The company is reviewing the Commission’s order and intends to appeal the decision. The EC decision follows last week’s ruling by US Federal Trade Commission judge in favor of Illumina’s acquisition of GRAIL. “We are disappointed with […]
WASHINGTON — Illumina, Inc. (NASDAQ:ILMN), today received a favorable decision from the Administrative Law Judge (ALJ) presiding over the Federal Trade Commission’s (FTC) challenge of the GRAIL acquisition. In the decision, the ALJ ruled for Illumina and rejected the FTC’s position that the deal would adversely affect competition in a putative market for multi-cancer early detection […]
Carlsbad CA and Research Triangle Park NC — CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin- associated proteins through the precise insertion of DNA sequences into the genome using the Tn5 transposase enzyme. EpiCypher and Active Motif each own or control patents covering complementary aspects of targeted […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that the United States Patent and Trademark Office issued US Patent No.11,359,244 on June 14, 2022. The patent, titled “CHARACTERIZATION OF MOLECULES IN NANOFLUIDICS” claims methods for the analysis of small nucleic acid fragments in nanochannel arrays, which Bionano has traditionally used to analyze ultra-high […]
Protein Metrics received patents across several application areas – data compression, interactive analysis and intact mass reconstruction CUPERTINO, Calif. — Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software and part of the Dotmatics family of scientific R&D software, announced today the granting of three new US patents. The patent names and numbers […]
Bagneux (France) – Genomic Vision (the “Company” – FR0011799907 – GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announces the successful publication of the patent on “Physical Characterization of Telomeres” (PCT). The patent was granted by the U.S. Patent and Trademark Office […]
Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to report that India Patent No. 397884 was granted on May 27, 2022. This patent covers methods and compositions for use of CRISPR/Cas9 and chimeric Cas9 in all cell types including eukaryotic cells. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to this foundational CRISPR/Cas9 […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
